News Releases

Webcast

AtriCure, Inc. at the 38th Annual JP Morgan Healthcare Conference

01/16/20 9:30 AM PST

Webcast Presentation

Webcast

AtriCure, Inc. at the Piper Jaffray 31st Annual Healthcare Conference

12/05/19 12:30 PM EST

Webcast Presentation

Webcast

AtriCure, Inc. at Stifel 2019 Healthcare Conference

11/20/19 9:45 AM EST

Webcast Presentation

Webcast

Q3 2019 AtriCure, Inc. Earnings Conference Call

10/30/19 4:30 PM EDT

Webcast Presentation

Webcast

Acquisition of SentreHEART by AtriCure Conference Call

08/12/19 8:30 AM EDT

Webcast Presentation

Date	Title
01/13/20	AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2019, Provides Financial Outlook for 2020 MASON, Ohio --(BUSINESS WIRE)--Jan. 13, 2020-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, announced preliminary financial results for the fourth quarter and full year 2019 and provided 2020 financial
01/07/20	AtriCure Announces Successful Completion of Patient Enrollment of aMAZE Clinical Trial and FDA Approval of Continued Access Protocol MASON, Ohio --(BUSINESS WIRE)--Jan. 7, 2020-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced the successful completion of patient enrollment in the aMAZE™ clinical trial.

Search form